8-K: Clorox Q3 Fiscal Year 2025 Results: Sales Dip Amidst Volatile Environment, Margin Expansion Continues

Clorox reported lower-than-expected sales for Q3 2025 due to a challenging consumer and geopolitical landscape, but maintained market share and achieved its tenth consecutive quarter of gross margin expansion.

Summary

• Clorox reported a net sales decrease of 8% to $1.67 billion for Q3 2025, primarily due to the divestitures of the VMS and Argentina businesses.
• Organic sales decreased by 2%, driven by an unfavorable price mix, while organic volume remained flat.
• Gross margin increased by 240 basis points to 44.6%, driven by cost savings and divestiture benefits.
• Diluted EPS increased significantly to $1.50 from a loss of $0.41 in the prior year, benefiting from lapping the Argentina divestiture loss and cyberattack insurance recoveries.
• Adjusted EPS decreased by 15% to $1.45, primarily due to lower net sales, partially offset by higher gross margin.
• The company is updating its fiscal year 2025 outlook, now expecting net sales to be down 1% to flat and organic sales to grow 4% to 5%.
• Gross margin for fiscal year 2025 is expected to be up about 150 basis points.
• Fiscal year diluted EPS is now expected to be between $5.73 and $6.13, while adjusted EPS is expected to be between $6.95 and $7.35.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While sales declined, the company is managing costs effectively, expanding margins, and maintaining market share. The updated outlook suggests continued growth, albeit at a moderated pace.

Positives

• Gross margin expanded for the tenth consecutive quarter, reaching 44.6%.
• Year-to-date net cash provided by operations increased significantly by 94% to $687 million.
• Clorox maintained overall market shares despite complex geopolitical and macroeconomic conditions.
• The company achieved zero-waste-to-landfill status across all global manufacturing plants where infrastructure allows.
• Diluted EPS increased significantly to $1.50 from a loss of $0.41 in the prior year, benefiting from lapping the Argentina divestiture loss and cyberattack insurance recoveries.

Negatives

• Net sales decreased by 8% to $1.67 billion.
• Organic sales decreased by 2% due to unfavorable price mix.
• Adjusted EPS decreased by 15% to $1.45.
• The company expects slowdowns to persist in the fourth quarter, as reflected in the updated outlook.

Risks

• Heightened macroeconomic uncertainties are driving changes in shopping behaviors, resulting in temporary category slowdowns and lower sales.
• The company faces risks related to unfavorable general economic and geopolitical conditions, including supply chain disruptions, rising inflation, and unstable geopolitical conditions.
• The company's recovery from the August 2023 cyberattack and risks related to the company's use of and reliance on information technology systems.

Future Outlook

The company expects net sales to be down 1% to flat for fiscal year 2025, with organic sales growth of 4% to 5%. Gross margin is expected to be up about 150 basis points. Diluted EPS is projected to be between $5.73 and $6.13, and adjusted EPS is expected to be between $6.95 and $7.35.

Management Comments

• In the third quarter, heightened macroeconomic uncertainties drove changes in shopping behaviors, resulting in temporary category slowdowns and lower sales.
• Despite this, our fundamentals remain strong as we held overall market shares and continued to expand margin while investing in our trusted brands.
• In this dynamic environment, we still expect to deliver organic sales growth and another year of strong earnings growth.
• I am confident in our ability to navigate the short-term given our strong brands and capabilities, while we continue to advance our long-term IGNITE strategy.

Industry Context

Clorox's results reflect the broader challenges faced by consumer goods companies in a volatile macroeconomic environment, including changing consumer behavior and geopolitical uncertainties. Maintaining market share and expanding margins are key priorities in this environment.

Comparison to Industry Standards

• Comparable companies like Procter & Gamble (PG) and Unilever (UL) are also navigating similar macroeconomic headwinds, focusing on cost management and portfolio optimization.
• Clorox's gross margin expansion is a positive sign, as many competitors are struggling with inflationary pressures.
• The impact of divestitures on Clorox's sales is similar to strategies employed by other large consumer goods companies to streamline their portfolios and focus on core brands.
• Clorox's digital transformation investments align with industry trends towards enhancing supply chain efficiency and improving customer engagement, similar to initiatives undertaken by companies like Nestle (NESN).

Stakeholder Impact

• Shareholders may be concerned about the sales decline but encouraged by the margin expansion and earnings growth outlook.
• Employees may be affected by ongoing cost management efforts and strategic investments.
• Customers may see continued product innovation and brand investment.
• Suppliers may experience changes in demand based on the company's sales performance.

Next Steps

• The company will post prepared management remarks regarding its third quarter fiscal year 2025 results.
• The company will host a live Q&A audio webcast with Chair and CEO Linda Rendle and Chief Financial Officer Luc Bellet to discuss the results.

Key Dates

Keywords

Clorox, financial results, Q3 2025, net sales, organic sales, gross margin, EPS, outlook, divestiture, cyberattack, ERP transition